Indefinite Delivery Contract SPE2DB22D2211

This indefinite delivery contract was awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp as a single award prime vendor for pharmaceutical products. The contract has a potential value of $999,999,999 and period of performance through December 2025. Task orders described delivery of various pharmaceuticals, medical supplies, and vaccines to Defense Logistics Agency locations in Conshohocken, Pennsylvania, to be performed by Amerisourcebergen Drug Corp under its parent company Amerisourcebergen Corporation. Delivery orders ranged from under $100 to over $13,000 and included products for conditions like diabetes, infections, pain, seizures, and allergies. No set aside provisions were applied. As the logistics combat support agency for the Department of Defense, the Defense Logistics Agency routinely issues delivery orders against prime vendor contracts held by major pharmaceutical distributors to maintain medical stockpiles for military treatment facilities and ensure supply chain continuity worldwide.

The contract provides an open ordering vehicle for the Defense Logistics Agency to procure various pharmaceutical products and medical supplies from Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, operating as the prime vendor. Task orders described delivery of medications, vaccines, and medical devices to Conshohocken, Pennsylvania by fixed completion dates ranging from September 2023 through December 2025. Delivery orders awarded against the contract spanned a wide value spectrum to fulfill diverse product needs, but consistently cited the Defense Logistics Agency's mandate to support military medical readiness as the purpose of procurements made.